SJS Investment Consulting’s iShares Biotechnology ETF IBB Stock Holding History

SJS Investment Consulting’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6	Closed	-$1.01K	–	2525
2025 Q4	$1.01K	Buy	+6	New	+$975	﹤0.01%	1291
2024 Q3	–	Sell	-122	Closed	-$16.7K	–	1683
2024 Q2	$16.7K	Hold	122	–	–	﹤0.01%	285
2024 Q1	$16.7K	Buy	122 +101	+481%	+$13.8K	﹤0.01%	299
2023 Q4	$2.85K	Sell	21 -100	-83%	-$12.2K	﹤0.01%	532
2023 Q3	$14.8K	Hold	121	–	–	﹤0.01%	256
2023 Q2	$15.4K	Hold	121	–	–	﹤0.01%	246
2023 Q1	$15.6K	Hold	121	–	–	﹤0.01%	245
2022 Q4	$15.9K	Buy	121 +100	+476%	+$12.9K	﹤0.01%	248
2022 Q3	$2K	Buy	+21	New	+$2.61K	﹤0.01%	473
2022 Q1	$3K	Hold	21	–	–	﹤0.01%	479
2021 Q4	$3K	Buy	+21	New	+$3.25K	﹤0.01%	453

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SJS Investment Consulting's IBB Position: Q1 2026 in Review

SJS Investment Consulting sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 6 shares — an estimated $1.01K sold.

SJS Investment Consulting first reported a position in IBB in Q4 2021 and held it in 11 quarters. The position peaked at $16.7K in Q2 2024. 921 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

SJS Investment Consulting reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
SJS Investment Consulting sold 6 iShares Biotechnology ETF shares in Q1 2026, an estimated $1.01K.
SJS Investment Consulting first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 11 quarters.
SJS Investment Consulting's iShares Biotechnology ETF position peaked at $16.7K in Q2 2024.
921 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on SJS Investment Consulting's 13F filing for Q1 2026, filed 23 Apr 2026.